Sequent Scientific board to meet for half-year financial results

Sequent Scientific Limited will hold a Board of Directors meeting on Friday, November 14, 2025. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. This intimation is made in accordance with Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

As per the company's code of conduct, the trading window for dealing in Sequent Scientific securities remains closed. This closure, which began on October 01, 2025, will continue until 48 hours after the announcement of the financial results, specifically up to November 16, 2025. This measure is in place to regulate, monitor, and report trading by designated persons and their immediate relatives.

The company's registered office is in Hyderabad, Telangana, while its corporate office is located in Thane (W), Mumbai, Maharashtra. Yoshita Vora serves as the company secretary and compliance officer.